Severe human psittacosis requiring artificial ventilation: case report and review. 1995

P E Verweij, and J F Meis, and R Eijk, and W J Melchers, and J M Galama
Department of Medical Microbiology, University Hospital Nijmegen, The Netherlands.

Severe respiratory failure is an uncommon manifestation of psittacosis. We describe a patient with psittacosis who developed severe respiratory failure and required artificial ventilation. We also review 11 cases reported in the English-language literature over the past 30 years. A history of exposure to birds was reported in 10 of 12 cases and remains the most significant risk factor. Severe hypoxemia or renal impairment was associated with a poor prognosis. Eight patients died of psittacosis or related complications of the infection. Diagnostic aspects, clinical manifestations, and management options are discussed.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009956 Psittacosis Infection with CHLAMYDOPHILA PSITTACI (formerly Chlamydia psittaci), transmitted to humans by inhalation of dust-borne contaminated nasal secretions or excreta of infected BIRDS. This infection results in a febrile illness characterized by PNEUMONITIS and systemic manifestations. Ornithosis,Ornithoses,Psittacoses
D012121 Respiration, Artificial Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2). Ventilation, Mechanical,Mechanical Ventilation,Artificial Respiration,Artificial Respirations,Mechanical Ventilations,Respirations, Artificial,Ventilations, Mechanical
D012131 Respiratory Insufficiency Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed) Acute Hypercapnic Respiratory Failure,Acute Hypoxemic Respiratory Failure,Hypercapnic Acute Respiratory Failure,Hypercapnic Respiratory Failure,Hypoxemic Acute Respiratory Failure,Hypoxemic Respiratory Failure,Respiratory Depression,Respiratory Failure,Ventilatory Depression,Depressions, Ventilatory,Failure, Hypercapnic Respiratory,Failure, Hypoxemic Respiratory,Failure, Respiratory,Hypercapnic Respiratory Failures,Hypoxemic Respiratory Failures,Respiratory Failure, Hypercapnic,Respiratory Failure, Hypoxemic,Respiratory Failures
D002691 Chlamydophila psittaci A genus of CHLAMYDOPHILA infecting primarily birds. It contains eight known serovars, some of which infect more than one type of host, including humans. Chlamydia psittaci
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

P E Verweij, and J F Meis, and R Eijk, and W J Melchers, and J M Galama
January 1983, The Alabama journal of medical sciences,
P E Verweij, and J F Meis, and R Eijk, and W J Melchers, and J M Galama
March 1954, Bulletin. Moore-White Medical Foundation, Los Angeles,
P E Verweij, and J F Meis, and R Eijk, and W J Melchers, and J M Galama
February 2019, Acta medica portuguesa,
P E Verweij, and J F Meis, and R Eijk, and W J Melchers, and J M Galama
May 2023, Radiology case reports,
P E Verweij, and J F Meis, and R Eijk, and W J Melchers, and J M Galama
June 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
P E Verweij, and J F Meis, and R Eijk, and W J Melchers, and J M Galama
April 1987, British medical journal (Clinical research ed.),
P E Verweij, and J F Meis, and R Eijk, and W J Melchers, and J M Galama
February 2001, The Journal of maternal-fetal medicine,
P E Verweij, and J F Meis, and R Eijk, and W J Melchers, and J M Galama
May 2020, The journal of obstetrics and gynaecology research,
P E Verweij, and J F Meis, and R Eijk, and W J Melchers, and J M Galama
November 1976, Annales de pediatrie,
Copied contents to your clipboard!